Skip to content

Evaluation of Skeletal Muscle Function Using Ultrasonic Elastography

Evaluation of Skeletal Muscle Function in Patients With Chronic Obstructive Pulmonary Disease Before and After Lung Rehabilitation Training Using Ultrasonic Elastography

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT05805332
Enrollment
60
Registered
2023-04-10
Start date
2023-04-07
Completion date
2024-12-31
Last updated
2023-04-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Obstructive Pulmonary Disease

Brief summary

The goal of observational study is to evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography in Chronic Obstructive Pulmonary Disease. The main question it aims to answer are:Evaluation of skeletal muscle function in patients with chronic obstructive pulmonary disease before and after lung rehabilitation training using ultrasonic elastography. Participants will undergo pulmonary rehabilitation.

Interventions

OTHERpulmonary rehabilitation

The participants would undergo pulmonary rehabilitation.

Sponsors

China-Japan Friendship Hospital
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
40 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* The age is between 40-80 years old * Patients with chronic obstructive pulmonary disease who meet the diagnostic criteria of GOLD guideline(2019) * There was no acute exacerbation in the past 12 weeks

Exclusion criteria

* Hypoxemia (oxygen partial pressure is less than 60mmHg or oxygen saturation is less than 88% at rest), or patients who need continuous oxygen inhalation, or patients with any contraindication to exercise test (refer to the American Thoracic Association/American Association of Thoracic Physicians exercise test guidelines) * Oral glucocorticoids * Receive long-term oxygen therapy prescription * Have participated in supervised exercise programs in the past 12 months * History of other lung diseases, including pneumoconiosis, bronchiectasis, tuberculosis, primary pulmonary hypertension, pulmonary embolism, interstitial lung disease * Diseases that restrict the active exercise ability of participants or involve skeletal, neuromuscular, cardiovascular or metabolic disorders of muscle activity, such as tumors, diabetes, muscle weakness, etc

Design outcomes

Primary

MeasureTime frameDescription
Effectiveness of pulmonary rehabilitation trainingbaseline6-minute walking distance (6MWD)

Secondary

MeasureTime frameDescription
Forced Expiratory Volume in 1-second(FEV1)before pulmonary rehabilitationPulmonary function test
Ultrasonic elastic imaging of rectus femorisbefore pulmonary rehabilitationUltrasonic elastography of skeletal muscle

Contacts

Primary ContactMingming Deng, MD
isdeng1017@163.com86 18801336854

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026